Levetiracetam in the Management of Bipolar Depression

Completed · Not applicable · Has a placebo group

Conditions studied: Bipolar Depression

In brief

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.

Key facts

Study ID

NCT00566150

Run by

Yale University

People needed

35

Starts

2005-10-01

Expected to finish

2008-08-01

Last updated by the study team

2020-03-31

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV diagnosis of bipolar disorder
• Presence of a current major depressive episode on the SCID
• Score of 17 or great on the HDRS
• Capable of giving voluntary written consent

You may not qualify if…

• Significant current substance dependence/abuse within 3 months preceding the trial
• Active suicidal ideation
• Pregnant/lactating mothers
• Significant medical history

Where it is running

• Yale University School of Medicine — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.